Viewing Study NCT02875132


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-04-18 @ 10:29 PM
Study NCT ID: NCT02875132
Status: COMPLETED
Last Update Posted: 2025-04-18
First Post: 2016-08-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma
Sponsor: Chinese University of Hong Kong
Organization: